Your one comprehensive BIOLOGICS partner Helping simplify your process and deliver better therapies to your patients faster Play Video Integrated Fill/Finish Solutions Your trusted partner for clinical and commercial fill finish and final product supply Learn More Comprehensive Biomanufacturing Solutions Your trusted partner for flexible clinical and commercial biomanufacturing Learn More Proven Technologies Create next generation therapies leveraging our suite of proprietary technology platforms Learn More Your one comprehensive BIOLOGICS partner Helping simplify your process and deliver better therapies to your patients faster Play Video Integrated Fill/Finish Solutions Your trusted partner for clinical and commercial fill finish and final product supply Learn More Comprehensive Biomanufacturing Solutions Your trusted partner for flexible clinical and commercial biomanufacturing Learn More Proven Technologies Create next generation therapies leveraging our suite of proprietary technology platforms Learn More How can we work together BiologicsDevelopment Drug SubstanceBiomanufacturing Drug ProductFill / Finish Clinical SupplyServices Latest News Debate on Patient-Focused Biologic Design to be Led by Catalent at Drug Delivery Partnerships WEBINAR: CONTINUOUS PROCESSING IN BIOMANUFACTURING There are many factors to consider when determining whether to adopt continuous processing. This webinar discusses a study comparing continuous and batch processing and challenges of adopting. Analytical Comprehensive integrated and standalone bioanalytical services for drug substance, drug product and intermediates, both new biologic entities and biosimilars/biobetters. Join Our Team Catalent is growing in Biologics and is making significant investments in people in this area. Explore global career opportunities with our Biologics team. Biologics Network Our network of biologics sites provides an integrated approach to get medicines to your patients faster anywhere in the world. See all of our locations NEWS Debate on Patient-Focused Biologic Design to be Led by Catalent at Drug Delivery Partnerships Assay Automation to be Presented by Catalent Biologics Expert at WCBP Symposium Catalent Invests $200 Million to Expand Biologics Capacity and Capabilities Catalent Invests $14 Million To Expand Biologics Packaging Capabilities Following Twentieth Commercial Drug Approval At Bloomington, Indiana Site EVENTS BEBPA US Bioassay Conference ISPE Aseptic Conference DCAT Week BIO-Europe Spring EXPERT CONTENT Advances in Analytical Technology for Biopharmaceuticals Prefilled Syringes & Parental Manufacturing Accelerating Method Transfer: Effective Automation Of Biological Assays
